Contributor content
Presentation
Relation of lymphopenia to comorbidity burden and its prognostic value in patients with acute decompensated heart failure with preserved left ventricular ejection fraction: a multicentre study
Presentation
Effect of empagliflozin as add-on therapy on transtubular potassium concentration gradient in patients with type 2 diabetes hospitalized for acute decompensated heart failure
Presentation
Effect of empagliflozin as add-on therapy on serum uric acid level in patients with type 2 diabetes hospitalized for acute decompensated heart failure: a prospective randomized controlled study
Presentation
Effect of empagliflozin as add-on therapy on decongestion and renal function in diabetic patients hospitalized for acute decompensated heart failure: a prospective randomized controlled study
Presentation
Plasma volume status is associated with the change in nutritional status during hospitalization in acute decompensated heart failure patients with preserved left ventricular ejection fraction
Presentation
Usefulness of 2-year iodine-123 metaiodobenzylguanidine-based risk model for the post-discharge risk stratification in patients with acute decompensated heart failure
Presentation
Comparison of the prognostic values of formulas for the estimation of plasma volume in patients admitted for acute decompensated heart failure: a prospective study
Presentation
Prediction of mode of death by calculated plasma volume status in patients admitted for acute decompensated heart failure: a prospective study of Osaka Prefectural Acute heart failure Registry (OPAR)
Presentation
Incremental prognostic value of plasma volume status and I-123 MIBG imaging in patients admitted for acute decompensated heart failure with reduced or preserved left ventricular ejection fraction
Presentation
